Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00987545
Recruitment Status : Terminated (Negative pharmacodynamics due to lack of Interleukin-13 signature in biomarker data from Part I of the study.)
First Posted : October 1, 2009
Last Update Posted : May 4, 2012
TKL Research, Inc.
Dermatology Consulting Services, High Point NC
Skin Search
Virginia Clinical Research, Inc.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2010
  Actual Study Completion Date : November 2010
  Certification/Extension First Submitted : May 2, 2012